Alleletyping of an oligodendrocyte-type-2 astrocyte lineage derive from a human glioblastoma multiforme

被引:6
作者
Mao, X
Barfoot, R
Hamoudi, RA
Noble, M
机构
[1] Inst Canc Res, Haddow Labs, Sect Mol Carcinogenesis, Sutton SM2 5NG, Surrey, England
[2] Imperial Canc Res Fund, Human Cytogenet Lab, London WC2A 3PX, England
[3] Ludwig Inst Canc Res, London W1P 8BT, England
[4] Univ Utah, Hlth Sci Ctr, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
基金
英国惠康基金;
关键词
alleletyping; oligodendrocyte-type-2; astrocyte; glioblastoma multiforme; loss of heterozygosity;
D O I
10.1023/A:1006158010388
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have conducted alleletyping of two novel cell lines derived from glioblastoma multiforme, which appear to have arisen from different glial lineages, by using 76 fluorescently labeled oligonucleotide primers amplifying microsatellite loci covering the entire human genome. One cell line, Hu-O-2A/Gb1, expresses antigens and metabolic profiles characteristic of the oligodendrocyte-type-2 astrocyte (0-2A) lineage of the rat central nervous system. This cell line generated, in vitro, cells with characteristics of 0-2A progenitor cells, oligodendrocytes and astrocytes. The second cell line, IN1434, is derived from an astrocyte or a precursor cell restricted to astrocytic differentiation. Hu-O-2A/Gb1 cells show allelic losses of loci on chromosomes 2, 5, 6, 7, 8, 9, 10, 11, 13, 15, 16, 17, 20 and 21. IN1434 cells are likely to have allelic losses of loci on chromosomes 1, 3, 8 and 10, although no control DNA is available for this cell line. These results, for the first time, provide a detailed information of the molecular genetic defects occurring in Hu-O-2A/Gb1 and IN1434.
引用
收藏
页码:243 / 250
页数:8
相关论文
共 58 条
[11]  
FULTS D, 1990, CANCER RES, V50, P5784
[12]  
Furnari FB, 1995, CANCER SURV, V25, P233
[13]   THE 1993-94 GENETHON HUMAN GENETIC-LINKAGE MAP [J].
GYAPAY, G ;
MORISSETTE, J ;
VIGNAL, A ;
DIB, C ;
FIZAMES, C ;
MILLASSEAU, P ;
MARC, S ;
BERNARDI, G ;
LATHROP, M ;
WEISSENBACH, J .
NATURE GENETICS, 1994, 7 (02) :246-339
[14]   THE MOLECULAR-BASIS OF TURCOTS-SYNDROME [J].
HAMILTON, SR ;
LIU, B ;
PARSONS, RE ;
PAPADOPOULOS, N ;
JEN, J ;
POWELL, SM ;
KRUSH, AJ ;
BERK, T ;
COHEN, Z ;
TETU, B ;
BURGER, PC ;
WOOD, PA ;
TAQI, F ;
BOOKER, SV ;
PETERSEN, GM ;
OFFERHAUS, GJA ;
TERSMETTE, AC ;
GIARDIELLO, FM ;
VOGELSTEIN, B ;
KINZLER, KW .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (13) :839-847
[15]  
Ichimura K, 1998, GENE CHROMOSOME CANC, V22, P9, DOI 10.1002/(SICI)1098-2264(199805)22:1<9::AID-GCC2>3.0.CO
[16]  
2-1
[17]  
Ishwad CS, 1997, GENE CHROMOSOME CANC, V19, P156, DOI 10.1002/(SICI)1098-2264(199707)19:3<156::AID-GCC4>3.0.CO
[18]  
2-X
[19]   ANTIONCOGENES AND HUMAN CANCER [J].
KNUDSON, AG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :10914-10921
[20]  
Koike M, 1997, GENE CHROMOSOME CANC, V19, P1, DOI 10.1002/(SICI)1098-2264(199705)19:1<1::AID-GCC1>3.0.CO